摘要
排斥反应是引起肾移植术后移植肾功能障碍的重要原因之一 ,对新型免疫抑制剂的研究是有效的预防和治疗排斥反应的重要方法。
出处
《国外医学（泌尿系统分册）》
2003年第1期28-31,共4页
Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
参考文献2
-
1Guido Filler,Jutta Gellermann,Miriam Zimmering,Ingrid Mai. Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity[J] 2000,Transplant International(3):201～206
-
2E. Nowacka-Cieciura,B. Kami?ska,T. Cieciura,L. Gradowska,J. Pazik,M. Lao,W. Rowi?ski,L. P?czek. Randomised open clinical trial of conversion from mycophenolate mofetil to azathioprine in cadaveric renal transplantation[J] 2000,Transplant International(1):S68～S72
同被引文献14
-
1王申东,孙倩,丁静.新型免疫抑制剂——吗替麦考酚酯[J].齐鲁药事,2005,24(6):382-382. 被引量：7
-
2周淑青,郑国钢,高素英,虞和永.HPLC测定吗替麦考酚酯的含量及有关物质[J].中国药学杂志,2007,42(10):780-782. 被引量：9
-
3Allison A C,Eugui E M. Mycophenolate mofetil and its mechanisms of action[J]. Immunophamiacology,2000,47(2,3):85-118.
-
4The Mycophenolate Mofetil Acute Renal Rejection Study Group. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up[J]. Transplantation,2001,71 (8) : 1091-1097.
-
5The Mycophenolate Mofetil Acute Renal Rejection Study Group. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection:three-year follow-up[J ]. Transplantation, 2001,71 (8) : 1091 - 1097.
-
6Katffman D B, Leventhal J R, Gallon L G, et al . Technical and immunologic progress in simultaneous pancreas-kidney transplantation[J]. Surgery,2002,132(4) :545 - 554.
-
7Allison A C, Eugui E M. Mycophenolate mofetil and its mechanisms of action[J], Immunopharmacology, 2000,47(2 - 3) :85 - 118.
-
8Triemer H L, Pearson T C, Odom K L, et ol. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation[J]. Clin Transplant, 2000,14(4 Pt 2) :413 -420.
-
9Ojo A O, Meier-Kriesche H U, Hanson J A, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection[J]. Transplantation, 2000,69(11) :2405 - 2409.
-
10Arnold A N, Wombolt D G, Whelan T V, et al. Mycophenolate mofetil, with cyclosporine and prednisone, reduces early rejection while allowing the use of less antilymphocytic agent induction and cyclosporine in renal recipients with delayed graft function[J]. Clin Transplant, 2000,14(4 Pt 2):421-426.
引证文献2
-
1周灵君,包贝华,郭戎.毛细管气相色谱法测定吗替麦考酚酯中的溶剂残留量[J].苏州科技学院学报（自然科学版）,2008,25(4):36-38. 被引量：1
-
2姜庆,靳风烁,李黔生,江军,方玉华,吴军.肾移植术后两种免疫抑制方案的对比研究[J].第三军医大学学报,2003,25(21):1912-1914. 被引量：1
二级引证文献2
-
1李文浩,苏泽轩,叶泽兵,黄明坦,陈航.肾移植术后肺部感染预后的Cox风险模型分析[J].器官移植,2015,6(3):179-183. 被引量：7
-
2李香荷,王强,郭毅,王柳,王韵,常俊山.气相色谱法测定吗替麦考酚酯原料中的11种残留溶剂[J].中国药师,2019,22(3):478-481. 被引量：5
-
1涂响安.雷帕霉素及其在肾移植中的应用[J].国外医学（泌尿系统分册）,2003,23(1):14-16.
-
2张勇.老年男性肾移植受者良性前列腺增生症的研究现状[J].山东医药,2011,51(8):1-2. 被引量：1
-
3匡长春,李晓东,汤韧.免疫抑制剂在肾移植中的应用进展[J].中国药房,2001,12(2):116-117. 被引量：3
-
4张秋林,陈东,蒋海霞.头孢他啶致尿毒症病人精神障碍1例报告[J].中外医疗,2008,27(12):119-119. 被引量：3
-
5申洪波,白云静,胡荫奇.类风湿性关节炎中西医结合治疗的思路与方法[J].中国骨伤,2004,17(8):503-504. 被引量：8
-
6李方方,徐燕丽,张秀群,张学忠.伏立康唑治疗侵袭性真菌感染有效性及安全性的Meta分析[J].实用药物与临床,2013,16(2):107-110. 被引量：10
-
7薛武军,郑瑾.重视组织配型和供者特异性抗体监测在肾移植中的重要作用[J].器官移植,2014,5(2):63-65. 被引量：5
-
8刘萍,刘毅.同种异体复合组织移植中免疫抑制剂的应用[J].中国美容整形外科杂志,2009,20(9):572-575. 被引量：1
-
9李聪颖.重度颅脑损伤并发真菌感染17例临床分析[J].中国现代医生,2009,47(19):73-73.
-
10胡金平,李文莉,陈新宙,胡春毓,聂薇萱,周海荣.口服布洛芬治疗早产儿动脉导管未闭临床观察[J].中国医师进修杂志,2007,30(12):61-62. 被引量：3
